1Fowell A J, lredale JP. Emerging therapies for liver fibrosis [J]. Dig Dis, 2006,24(1-2) : 174.
2Liu C, Hu Y, Xu L, et al. Effect of Fuzheng huayu formula and its actions against liver fibrosis[J]. Chinese Medicine, 2009,4: 12.
3Juni P, Altman DG, Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trails [J]. BMJ, 2001,323(7 303):42.
4Higgins JP, Thompson SG. Quantifying heterogeneity in a meta analysis[J]. Stat Med, 2002,21 ( 11 ) : 1 539.
5叶临湘.现代流行病学[M].北京:人民卫生出版社,2009:368.
6Dichersin K, Larson K. Definitions of RCT and CCT estabnishing and maintaining an international rigistera of RCTs[M]. Oxford. Cochrane Library, 1998: 56.
7Romero MR, Efferth T, Serrano MA, et al. Effect of arte-misinin/artesunate as inhibitors of hepatitis B virus production in an "in vitro" replicative system[J]. Antiviral Res, 2005,68(2) :75.
8Suzuki M, Sasaki K, Yoshizaki F, et al. Anti-hepatitis C virus effect of citrus unshiu peel and its active ingredient nobiletin[J]. Am J Chin Med, 2005,33( 1 ) : 87.
9Park WH, Lee SK, Kim CH. A Korean herbal medicine, panax notoginseng, prevents liver fibrosis and hepatic microvascular dysfunction in rats[J]. Life Sci, 2005,76( 15 ): 1 675.
10Liu X, Hu H, Yin JQ. Therapeutic strategies against TGF-beta signalling pathway in hepatic fibrosis[J]. Liver Int, 2006, 26(1).8.
